This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| transposable elements | |
|---|---|
| Name | Transposable elements |
| Domain | Cellular life |
transposable elements Transposable elements are DNA sequences capable of moving within genomes, first recognized through work that reshaped genetics in the 20th century. They were central to discoveries by researchers working at institutions such as Cold Spring Harbor Laboratory, University of California, Berkeley, and Cornell University, and influenced concepts explored in events like the Cold Spring Harbor Symposium and awards such as the Nobel Prize in Physiology or Medicine. Studies of transposable elements have intersected with research on model organisms including Drosophila melanogaster, Zea mays, Mus musculus, and Escherichia coli.
Transposable elements were experimentally characterized by geneticists whose careers involved laboratories at University of Cambridge, Max Planck Society, and National Institutes of Health. Foundational descriptions emerged alongside work on Barbara McClintock's cytogenetic studies and later analyses at The Rockefeller University and Indiana University Bloomington. Their discovery influenced broader programs at organizations such as the Howard Hughes Medical Institute and synthetic biology initiatives at Massachusetts Institute of Technology. Transposable elements are discussed in reviews published in journals associated with Nature Publishing Group, Cell Press, and Proceedings of the National Academy of Sciences.
Classification schemes trace to comparative studies performed at centers like Stanford University, Harvard University, and Yale University Hospital. Major classes include DNA transposons characterized in experiments at Salk Institute for Biological Studies and retrotransposons identified in work at Fred Hutchinson Cancer Center and Scripps Research. Mechanistic categories—cut-and-paste, copy-and-paste, and replicative transposition—were elucidated through biochemical studies at Max Planck Institute for Molecular Genetics and computational analyses from groups at European Bioinformatics Institute and Wellcome Sanger Institute. Proteins mediating movement, such as transposases and reverse transcriptases, were biochemically characterized in laboratories affiliated with University of Oxford, University of Tokyo, and University of Paris.
Genomic surveys by consortia including the Human Genome Project, 1000 Genomes Project, and Ensembl revealed that transposable elements contribute substantially to genome size across taxa including Homo sapiens, Arabidopsis thaliana, Saccharomyces cerevisiae, and Oryza sativa. Comparative genomics initiatives at Broad Institute, Genome Institute at Washington University, and J. Craig Venter Institute showed lineage-specific expansions in clades studied by teams at Monash University, University of British Columbia, and University of California, Davis. Transposable element-driven rearrangements have been invoked to explain evolutionary events discussed in contexts like the Cambrian explosion and adaptive radiations investigated at Smithsonian Institution and Natural History Museum, London.
Regulatory interactions were mapped by laboratories at European Molecular Biology Laboratory, Cold Spring Harbor Laboratory, and Johns Hopkins University School of Medicine. Host defenses such as RNA-mediated silencing and epigenetic modifications were elucidated by researchers at Dana-Farber Cancer Institute, University of Geneva, and Beth Israel Deaconess Medical Center. Chromatin remodeling and DNA methylation influences on element activity were documented in collaborations involving Karolinska Institute, University of Melbourne, and Imperial College London. Studies of transcription factor binding and enhancer co-option referenced datasets from ENCODE Project Consortium and computational resources at National Center for Biotechnology Information.
Clinical links were investigated by clinicians and scientists affiliated with Mayo Clinic, Cleveland Clinic, and Memorial Sloan Kettering Cancer Center. Transposable element insertions have been implicated in monogenic disorders studied at Great Ormond Street Hospital and complex diseases analyzed by teams at University College London and Karolinska Institutet. Oncogenic activation, immune responses, and ageing-related expression changes were examined in studies connected to Stanford Cancer Institute, Dana-Farber Cancer Institute, and European Society for Medical Oncology. Associations with neurological conditions were pursued by researchers at Massachusetts General Hospital, University of Pennsylvania, and Yale School of Medicine.
Detection approaches were developed using sequencing platforms from companies such as Illumina, Pacific Biosciences, and Oxford Nanopore Technologies, and bioinformatics pipelines from groups at EMBL-EBI, Wellcome Sanger Institute, and Broad Institute. Experimental systems include transposition assays employed at Cold Spring Harbor Laboratory, reporter constructs used in facilities at Max Delbrück Center for Molecular Medicine, and genome editing adaptations made by teams at Zhejiang University and University of California, San Diego. Computational annotation methods were advanced by collaborations with European Bioinformatics Institute, National Human Genome Research Institute, and projects like GENCODE.
Biotechnological exploitation has been pursued by startups and institutions such as Editas Medicine, Intellia Therapeutics, Sangamo Therapeutics, and academic groups at University of Texas Southwestern Medical Center and Karolinska Institutet. Engineered transposon systems are used for mutagenesis screens in programs at Broad Institute and Wellcome Sanger Institute, for gene delivery in gene therapy trials coordinated with U.S. Food and Drug Administration oversight and translational research at University of Pennsylvania Perelman School of Medicine. Synthetic biology applications intersect with initiatives at MIT Media Lab and corporate research at Pfizer and Novartis. Conservation and ecological genomics projects involving transposable elements have been part of collaborations with World Wildlife Fund and museums such as American Museum of Natural History.